These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1594 related items for PubMed ID: 22858557

  • 1. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 3. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH, Kantele JM, Kantele A.
    Scand J Immunol; 2014 Mar 09; 79(3):222-9. PubMed ID: 24383914
    [Abstract] [Full Text] [Related]

  • 4. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH, Kantele JM, Herzog C, Kantele A.
    Vaccine; 2014 Jan 23; 32(5):544-51. PubMed ID: 24342246
    [Abstract] [Full Text] [Related]

  • 5. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A, Pakkanen SH, Siitonen A, Karttunen R, Kantele JM.
    Vaccine; 2012 Nov 26; 30(50):7238-45. PubMed ID: 23084770
    [Abstract] [Full Text] [Related]

  • 6. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC.
    Clin Infect Dis; 2007 Jul 15; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [Abstract] [Full Text] [Related]

  • 7. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Mucosal Immunol; 2015 Nov 15; 8(6):1349-59. PubMed ID: 25872480
    [Abstract] [Full Text] [Related]

  • 8. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Clin Immunol; 2016 Dec 15; 173():87-95. PubMed ID: 27634430
    [Abstract] [Full Text] [Related]

  • 9. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A, Pakkanen SH, Karttunen R, Kantele JM.
    PLoS One; 2013 Dec 15; 8(4):e60583. PubMed ID: 23593253
    [Abstract] [Full Text] [Related]

  • 10. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut.
    Kantele A, Kantele JM, Savilahti E, Westerholm M, Arvilommi H, Lazarovits A, Butcher EC, Mäkelä PH.
    J Immunol; 1997 Jan 15; 158(2):574-9. PubMed ID: 8992970
    [Abstract] [Full Text] [Related]

  • 11. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Jan 15; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 12. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R, Simon R, Zafar SJ, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2012 Jun 15; 19(6):825-34. PubMed ID: 22492745
    [Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K, Chen Z, Zhu C, Li J, Hu X, Rao X, Cong Y.
    Int J Med Microbiol; 2015 Sep 15; 305(6):563-71. PubMed ID: 26239100
    [Abstract] [Full Text] [Related]

  • 14. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E, Shlim DR, Eaton M, Jenks N, Houston R.
    Arch Intern Med; 1990 Feb 15; 150(2):349-51. PubMed ID: 2105702
    [Abstract] [Full Text] [Related]

  • 15. [Typhoid fever in school children: by what measures is the modification of the clinical course due to oral vaccination?].
    Contreras R, Ferreccio C, Sotomayor V, Astroza L, Berríos G, Ortiz E, Palomino C, Prenzel I, Pinto ME, Levine M.
    Rev Med Chil; 1992 Feb 15; 120(2):134-41. PubMed ID: 1340549
    [Abstract] [Full Text] [Related]

  • 16. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
    Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2014 Mar 15; 21(3):427-34. PubMed ID: 24429069
    [Abstract] [Full Text] [Related]

  • 17. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN, Hatz C, Kantele A.
    Expert Rev Vaccines; 2017 Oct 15; 16(10):1029-1043. PubMed ID: 28856924
    [Abstract] [Full Text] [Related]

  • 18. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 15; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 19. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S, Chowdhury R, Pal A, Okamoto K, Das S.
    Immunobiology; 2019 May 15; 224(3):371-382. PubMed ID: 30952553
    [Abstract] [Full Text] [Related]

  • 20. Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter.
    Kantele A, Arvilommi H, Iikkanen K, Savilahti E, Mäkelä HP, Herzog C, Fürer E, Kantele JM.
    J Infect Dis; 2005 Jan 15; 191(2):312-7. PubMed ID: 15609243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.